Organizational Overview:

Immunovant, Inc. is a clinical-stage biopharmaceutical company dedicated to enabling normal lives for people with autoimmune diseases. As trailblazers in FcRn inhibitor technology, the Company is boldly developing innovative therapies for a range of debilitating autoimmune diseases with significant unmet patient needs. The Company’s investigational product, batoclimab, is a fully human, monoclonal antibody that targets and binds to the neonatal Fc receptor (FcRn).

The Role:

Reporting to the Director, Site Management, this position should act as a local liaison between Immunovant, CRO CRAs and investigator sites in order to support program specific corporate targets (achieve or exceed), identify and mitigate potential issues and support oversight activities.

The SRM covers multiple Immunovant indications in the assigned country throughout the full life cycle of the trial. Key focus areas are to facilitate optimal clinical trial set-up, execution and quality by:

  • Understanding the local environment.
  • Create and maintain strong, long-term relationships with sites.
  • Support applicable Immunovant Teams in CRO and Sponsor site oversight activities.

Key Responsibilities: 

Understanding the local environment:

  • Obtain relevant knowledge about the assigned region - treatment standards, patient pathways, healthcare system, competitive landscape, clinical trial regulatory environment, patient advocacy groups, Key Opinion Leaders (KOLs), site capabilities and past performance etc.
  • Assist applicable Immunovant Teams with creation of country specific plans to target appropriate national patient support/advocacy groups in order to influence patient recruitment.
  • Attend local medical/support group meetings and conferences as needed.
  • Use local expertise to collaborate closely with applicable Immunovant Teams and CROs and support start-up activities as needed, to ensure high quality feasibility data collected and qualified sites selected. 
  • Provide input to applicable Immunovant Teams’ site level recruitment targets and recruitment methodologies (enrolment plan).
  • Understand local and country regulatory authority and EC requirements to provide support during regulatory and EC submissions and approvals.

Create and maintain strong, long-term relationships with sites:

  • Create strong relationships with all relevant site personnel in order to facilitate timely meeting of clinical trial targets (ie, enrollment, data entry, query resolution, etc).
  • Site motivation visits to boost screening and enrollment activities.
  • Work closely with applicable Immunovant Teams, CRO CRAs and sites to support site enrolment. Understand patient journey at the site in order to ensure that no potential subjects are lost. Create/support site risk plans where applicable.
  • Work proactively with sites to resolve/mitigate any issues, share learnings from other sites, and manage any requests in collaboration with applicable Immunovant Teams.
  • Keep internal stakeholders oriented about relevant issues and share insights about the sites.

Support applicable Immunovant Teams in CRO and Sponsor site oversight activities:

  • Create a close, trustful, and engaged collaboration with counterparts in CRO, in order to have joint strategy for meeting the trial targets. Lead/attend joint regular local/global CRO/SRM meetings.
  • Support CRO CRAs and applicable Immunovant Teams to ensure each site’s on time delivery of database lock milestones.
  • Based on communication with sites, report/discuss learnings and escalate issues identified to applicable Immunovant Teams. Support any site issue mitigation strategies as needed.
  • Support oversight of site-level CRO activities to ensure quality of site and CRO:
    • Monitoring Oversight visits to focus on both CRA and site performance. During visit, review previously monitored patients, ensuring compliance with SOPs, protocol, ICH GCP and applicable regulatory requirements.
    • Review relevant site-specific metrics to keep track of site performance.
    • Follow up with site on any concerns raised by applicable Immunovant Teams.

Site visit expectations:

SRM to visit all sites Face-To-Face when relationship initiated, and as needed throughout the trial. Virtual meetings may be arranged as well. Key sites may be identified to be visited Face-To-Face more frequently than others.

Types of SRM visits:

  • Site visits prior to Site Initiation Visit, to ensure site is ready for start-up and help resolve issues hindering activation.
  • Site Initiation Visit (CRO CRA owns the meeting, SRM and/or CTM attends as sponsor representative).
  • Enrolment booster visits.
  • Monitoring Oversight visits.
  • Ad hoc site training/re-training visits, as agreed with applicable Immunovant Teams.


  • Bachelors or Masters degree in Life Science.
  • At least 7 years of experience in the pharmaceutical/Clinical Research industry.
  • Minimum 5 years experience as Clinical Research Associate, Monitor or similar.
  • Significant experience in clinical research (especially site management) from Pharma, Biotech or CRO.
  • Demonstrated experience of working directly with investigator sites and investigators.
  • Strong knowledge of ICH GCP.
  • Demonstrated relationship building skills with investigator sites (on site and remote).
  • Excellent networking skills with internal and external stakeholders.
  • Excellent written and verbal communication skills (English and relevant local language(s)).
  • Excellent problem-solving skills.
  • Self-motivated with proactive issue monitoring and management, including risk assessment and contingency planning.
  • Combination of critical thinking and operational expertise and efficiency.
  • Experience in clinical trials with rare diseases is preferred.
  • Experience in cross-country and cross-functional collaboration is a strong plus.

Work Environment:

  • Dynamic, interactive, fast-paced, and entrepreneurial environment
  • The position will be located in US, and Canada as a fully remote work position.
  • Travel to clinical sites and occasionally Immunovant corporate locations is required (35-50%).

Apply for this Job

* Required
resume chosen  
(File types: pdf, doc, docx, txt, rtf)
cover_letter chosen  
(File types: pdf, doc, docx, txt, rtf)

Voluntary Self-Identification

For government reporting purposes, we ask candidates to respond to the below self-identification survey. Completion of the form is entirely voluntary. Whatever your decision, it will not be considered in the hiring process or thereafter. Any information that you do provide will be recorded and maintained in a confidential file.

As set forth in IMVT Corporation’s Equal Employment Opportunity policy, we do not discriminate on the basis of any protected group status under any applicable law.

Race & Ethnicity Definitions

If you believe you belong to any of the categories of protected veterans listed below, please indicate by making the appropriate selection. As a government contractor subject to the Vietnam Era Veterans Readjustment Assistance Act (VEVRAA), we request this information in order to measure the effectiveness of the outreach and positive recruitment efforts we undertake pursuant to VEVRAA. Classification of protected categories is as follows:

A "disabled veteran" is one of the following: a veteran of the U.S. military, ground, naval or air service who is entitled to compensation (or who but for the receipt of military retired pay would be entitled to compensation) under laws administered by the Secretary of Veterans Affairs; or a person who was discharged or released from active duty because of a service-connected disability.

A "recently separated veteran" means any veteran during the three-year period beginning on the date of such veteran's discharge or release from active duty in the U.S. military, ground, naval, or air service.

An "active duty wartime or campaign badge veteran" means a veteran who served on active duty in the U.S. military, ground, naval or air service during a war, or in a campaign or expedition for which a campaign badge has been authorized under the laws administered by the Department of Defense.

An "Armed forces service medal veteran" means a veteran who, while serving on active duty in the U.S. military, ground, naval or air service, participated in a United States military operation for which an Armed Forces service medal was awarded pursuant to Executive Order 12985.

Form CC-305

OMB Control Number 1250-0005

Expires 05/31/2023

Voluntary Self-Identification of Disability

Why are you being asked to complete this form?

We are a federal contractor or subcontractor required by law to provide equal employment opportunity to qualified people with disabilities. We are also required to measure our progress toward having at least 7% of our workforce be individuals with disabilities. To do this, we must ask applicants and employees if they have a disability or have ever had a disability. Because a person may become disabled at any time, we ask all of our employees to update their information at least every five years.

Identifying yourself as an individual with a disability is voluntary, and we hope that you will choose to do so. Your answer will be maintained confidentially and not be seen by selecting officials or anyone else involved in making personnel decisions. Completing the form will not negatively impact you in any way, regardless of whether you have self-identified in the past. For more information about this form or the equal employment obligations of federal contractors under Section 503 of the Rehabilitation Act, visit the U.S. Department of Labor’s Office of Federal Contract Compliance Programs (OFCCP) website at

How do you know if you have a disability?

You are considered to have a disability if you have a physical or mental impairment or medical condition that substantially limits a major life activity, or if you have a history or record of such an impairment or medical condition.

Disabilities include, but are not limited to:

  • Autism
  • Autoimmune disorder, for example, lupus, fibromyalgia, rheumatoid arthritis, or HIV/AIDS
  • Blind or low vision
  • Cancer
  • Cardiovascular or heart disease
  • Celiac disease
  • Cerebral palsy
  • Deaf or hard of hearing
  • Depression or anxiety
  • Diabetes
  • Epilepsy
  • Gastrointestinal disorders, for example, Crohn's Disease, or irritable bowel syndrome
  • Intellectual disability
  • Missing limbs or partially missing limbs
  • Nervous system condition for example, migraine headaches, Parkinson’s disease, or Multiple sclerosis (MS)
  • Psychiatric condition, for example, bipolar disorder, schizophrenia, PTSD, or major depression

PUBLIC BURDEN STATEMENT: According to the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless such collection displays a valid OMB control number. This survey should take about 5 minutes to complete.